Pfizer Constructs Sanford Gene Therapy Facility

Published 9-12-2019
  • Pfizer - Sanford Gene Therapy Facility
  • Pfizer - Sanford Gene Therapy Facility

    Courtesy of Pfizer.

Pfizer is initiating a $500 million expansion of its Sanford campus with the construction of a 100,000-sf gene therapy facility. Supporting the creation of innovative treatments for genetic diseases, the project will feature advance manufacturing technologies for clinical and commercial-scale production of recombinant adeno-associated virus (rAAV) vectors. Accommodating 300 new employees, the facility will complement operations at the existing 628,000-sf Sanford complex and at the company's Chapel Hill and Kit Creek locations.